Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Exploration of Allograft Humoral Rejection in Chronic Histiocytic Intervillositis — Stella

Home/Chronic Histiocytic Intervillositis/Exploration of Allograft Humoral Rejection in Chronic Histiocytic Intervillositis

View on ClinicalTrials.gov

Recruiting

Back to Chronic Histiocytic Intervillositis trials

Exploration of Allograft Humoral Rejection in Chronic Histiocytic Intervillositis

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Antoine Béclère Hospital, Clamart

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~200 participants

Started

October 2023

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.